Dengfeng Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Dengfeng Zhang has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Wenkai Zhou
Department of Cardiovascular Surgery, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China
2 shared publications Caixia Sun
The First Affiliated Hospital, Department of Emergency, Hengyang Medical School, University of South China, Hengyang, China
1 shared publication- Feng Jiang
The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University
1 shared publication - Guojun Li
Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA
1 shared publication Hailong Qiu
Department of Cardiovascular Surgery, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China
1 shared publicationJia Xu
Department of Cardiovascular Surgery, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Human Mutation
- Vol. 2026 (1) , 1253577
Causal Mediation of Immune Cells and Fatty Acids in Coronary Atherosclerosis: Insights From Mendelian Randomization Analysis
Observational studies have suggested a link between total fatty acid levels and the development of coronary atherosclerosis. While the involvement of immune cells in the pathogenesis of this condition is well‐established, the precise causal mechanisms by which fatty acids influence immune cell function and subsequently affect coronary atherosclerosis remain unclear. To address this, we systematically assessed the causal relationships among 731 immune cell traits, circulating fatty acid levels, and coronary atherosclerosis using a two‐sample Mendelian randomization (MR) approach. Multivariable Mendelian randomization (MVMR) was further employed to investigate the potential mediating role of dendritic cells in the pathway linking fatty acids to coronary atherosclerosis. Our analysis identified significant causal associations between 30 immune cell traits and coronary atherosclerosis. Furthermore, circulating fatty acid levels were causally linked to an increased risk of coronary atherosclerosis. MVMR analysis revealed that dendritic cells, specifically the CD62L− CD86+ myeloid subset, partially mediate the causal effect of fatty acid levels on coronary atherosclerosis. This study provides genetic evidence supporting the causal roles of multiple immune cell traits and fatty acid levels in coronary atherosclerosis. Importantly, dendritic cells were identified as a key mediator in the pathway through which fatty acids influence disease risk. These findings offer new insights into the interplay between nutrition and immunity in atherosclerosis and highlight potential targets for future therapeutic and preventive strategies.
- 1 January 2026
- Published by Wiley in Human Mutation
- Vol. 2026 (1) , 1253577
Open AccessCausal Mediation of Immune Cells and Fatty Acids in Coronary Atherosclerosis: Insights From Mendelian Randomization Analysis
Observational studies have suggested a link between total fatty acid levels and the development of coronary atherosclerosis. While the involvement of immune cells in the pathogenesis of this condition is well‐established, the precise causal mechanisms by which fatty acids influence immune cell function and subsequently affect coronary atherosclerosis remain unclear. To address this, we systematically assessed the causal relationships among 731 immune cell traits, circulating fatty acid levels, and coronary atherosclerosis using a two‐sample Mendelian randomization (MR) approach. Multivariable Mendelian randomization (MVMR) was further employed to investigate the potential mediating role of dendritic cells in the pathway linking fatty acids to coronary atherosclerosis. Our analysis identified significant causal associations between 30 immune cell traits and coronary atherosclerosis. Furthermore, circulating fatty acid levels were causally linked to an increased risk of coronary atherosclerosis. MVMR analysis revealed that dendritic cells, specifically the CD62L− CD86+ myeloid subset, partially mediate the causal effect of fatty acid levels on coronary atherosclerosis. This study provides genetic evidence supporting the causal roles of multiple immune cell traits and fatty acid levels in coronary atherosclerosis. Importantly, dendritic cells were identified as a key mediator in the pathway through which fatty acids influence disease risk. These findings offer new insights into the interplay between nutrition and immunity in atherosclerosis and highlight potential targets for future therapeutic and preventive strategies.
- Open Access
- 13 March 2017
- Published by Tech Science Press in Oncology Research
- Vol. 25 (3) , 417-425
Knockdown of DDX46 Inhibits the Invasion and Tumorigenesis in Osteosarcoma Cells
DDX46, a member of the DEAD-box (DDX) helicase family, is involved in the development of several tumors. However, the exact role of DDX46 in osteosarcoma and the underlying mechanisms in tumorigenesis remain poorly understood. Thus, in the present study, we explored the role of DDX46 in osteosarcoma and the underlying mechanisms. Our results demonstrated that the expression levels of DDX46 in both mRNA and protein were greatly elevated in human osteosarcoma tissues and cell lines. Knockdown of DDX46 obviously inhibited osteosarcoma cell proliferation and tumor growth in vivo. In addition, knockdown of DDX46 also significantly suppressed migration and invasion in osteosarcoma cells. Furthermore, knockdown of DDX46 substantially downregulated the phosphorylation levels of PI3K and Akt in SaOS2 cells. In summary, the present results have revealed that DDX46 plays an important role in osteosarcoma growth and metastasis. Knockdown of DDX46 inhibited osteosarcoma cell proliferation, migration, and invasion in vitro and tumor growth in vivo. Therefore, DDX46 may be a potential therapeutic target for the treatment of osteosarcoma.
- 13 March 2017
- Published by Tech Science Press in Oncology Research
- Vol. 25 (3) , 417-425
Open AccessKnockdown of DDX46 Inhibits the Invasion and Tumorigenesis in Osteosarcoma Cells
DDX46, a member of the DEAD-box (DDX) helicase family, is involved in the development of several tumors. However, the exact role of DDX46 in osteosarcoma and the underlying mechanisms in tumorigenesis remain poorly understood. Thus, in the present study, we explored the role of DDX46 in osteosarcoma and the underlying mechanisms. Our results demonstrated that the expression levels of DDX46 in both mRNA and protein were greatly elevated in human osteosarcoma tissues and cell lines. Knockdown of DDX46 obviously inhibited osteosarcoma cell proliferation and tumor growth in vivo. In addition, knockdown of DDX46 also significantly suppressed migration and invasion in osteosarcoma cells. Furthermore, knockdown of DDX46 substantially downregulated the phosphorylation levels of PI3K and Akt in SaOS2 cells. In summary, the present results have revealed that DDX46 plays an important role in osteosarcoma growth and metastasis. Knockdown of DDX46 inhibited osteosarcoma cell proliferation, migration, and invasion in vitro and tumor growth in vivo. Therefore, DDX46 may be a potential therapeutic target for the treatment of osteosarcoma.